Abstract
Blockade of the CD40 ligand (CD40L)-CD40 interaction suppresses experimental autoimmune encephalomyelitis (EAE). Since this interaction induces IL-12, an essential cytokine for EAE induction, we hypothesized that CD40L blockade may suppress EAE through IL-12 inhibition. Here we show that exogenous IL-12 abolishes the ability of anti-CD40L monoclonal antibodies to prevent EAE. Anti-IL-12 antibodies prevent this reversal and protect from EAE. These results show that IL-12 is sufficient to overcome CD40L blockade and suggest that, of the multiple consequences of the CD40L-CD40 interaction, IL-12 induction is an essential one for induction of EAE.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antibodies, Monoclonal / pharmacology
-
CD40 Antigens / metabolism
-
CD40 Ligand
-
Crosses, Genetic
-
Encephalomyelitis, Autoimmune, Experimental / epidemiology
-
Encephalomyelitis, Autoimmune, Experimental / immunology*
-
Encephalomyelitis, Autoimmune, Experimental / metabolism
-
Encephalomyelitis, Autoimmune, Experimental / prevention & control
-
Guinea Pigs
-
Immunity, Cellular
-
Immunosuppression Therapy*
-
Incidence
-
Interleukin-12 / administration & dosage
-
Interleukin-12 / immunology*
-
Interleukin-12 / pharmacology*
-
Ligands
-
Membrane Glycoproteins / antagonists & inhibitors*
-
Membrane Glycoproteins / immunology
-
Mice
-
Mice, Inbred Strains
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / adverse effects*
-
Spinal Cord / immunology
Substances
-
Antibodies, Monoclonal
-
CD40 Antigens
-
Ligands
-
Membrane Glycoproteins
-
Recombinant Proteins
-
CD40 Ligand
-
Interleukin-12